| MR编号 | IE/H/1193/001 |
|---|
| 药品名称 | Plerixafor 20 mg/ml solution for injection |
|---|
| 活性成分 | |
|---|
| 剂型 | Solution for injection |
|---|
| 上市许可持有人 | Seacross Pharma (Europe) Ltd, Regus Dublin Airport, Skybridge House, Corballis Road North, Dublin Airport Swords, Dublin, K67 P6K2, Ireland |
|---|
| 参考成员国 - 产品名称 | Ireland (IE) |
|---|
| 互认成员国 - 产品名称 | - Croatia (HR)
- Sweden (SE)
- Norway (NO)
- Finland (FI)
- Poland (PL)
Plerixafor Biofar - Lithuania (LT)
Plerixafor Auxilia 20 mg/ml injekcinis tirpalas - Germany (DE)
Plerixafor Seacross 20 mg/ml Injektionslösung - Estonia (EE)
- Denmark (DK)
- Hungary (HU)
- Netherlands (NL)
Plerixafor Seacross 20 mg/ml, oplossing voor injectie - Czechia (CZ)
Plerixafor Onkogen - France (FR)
- Romania (RO)
Plerixafor Onkogen 20 mg/ml soluţie injectabilă - Spain (ES)
- Slovakia (SK)
- Portugal (PT)
- Slovenia (SI)
- Italy (IT)
|
|---|
| 许可日期 | 2023/02/05 |
|---|
| 最近更新日期 | 2023/10/20 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|